Human immunoglobulin for measles/hepatitis virus infection (Guangxi Beisheng Pharmaceutical)

人免疫球蛋白(广西北生药业)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin for measles/hepatitis virus infection (Guangxi Beisheng Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitisMeasles
Global Approved IndicationsHepatitisMeasles
Approved Indications in ChinaHepatitisMeasles
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHepatitisMeasles

Other Information

ATC CodeJ06BB
Related LinksN/A